3
项与 18F-MNI-1054 相关的临床试验A Phase 1, Open-label, Positron Emission Tomography Study With [18F]MNI-1054 to Determine Lysine-Specific Demethylase 1A Brain Enzyme Occupancy of TAK-418 After Single-Dose Oral Administration in Healthy Subjects
The purpose of this study is to determine brain LSD1 enzyme occupancy and the relationship of occupancy to TAK-418 dose and plasma exposure after single oral dosing of TAK-418 in healthy participants using [18F]MNI-1054 positron emission tomography (PET) imaging.
Assessment of the Biodistribution and Safety of [18F]MNI-1054 in Healthy Subjects
The overall goal of this protocol is to evaluate the biodistribution of [18F]MNI-1054 as a LSD1 targeted radiopharmaceutical.
An Open-label, Brain Positron Emission Tomography, Phase 0 Study of [18F]MNI-1054 as a Marker for LSD1 in Healthy Subjects
The primary objective of this protocol is to evaluate [18F]MNI-1054 as a Lysine-specific histone demethylase 1A (LSD1) enzyme targeted radiopharmaceutical.
100 项与 18F-MNI-1054 相关的临床结果
100 项与 18F-MNI-1054 相关的转化医学
100 项与 18F-MNI-1054 相关的专利(医药)
100 项与 18F-MNI-1054 相关的药物交易